Safety and Implementation of phase I randomized GLASEadjuvanted CH505TF gp120 HIV vaccine trial in newborns

dc.article.end-page9en
dc.article.start-page1en
dc.citation.doi10.1172/JCI186927en
dc.contributor.authorAvyi Violarien
dc.contributor.authorKennedy Otwombeen
dc.contributor.authorWilliam Hanhen
dc.contributor.authorShiyu Chenen
dc.contributor.authorDeirdre Josipovicen
dc.contributor.authorVuyelwa Babaen
dc.contributor.authorAsimenia Angelidouen
dc.contributor.authorKinga K Smolenen
dc.contributor.authorE et alen
dc.contributor.authorGlenda Grayen
dc.date.accessioned2025-08-01T09:42:28Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0021-9738en
dc.identifier.urihttps://hdl.handle.net/10539/45722
dc.journal.titleSafety and Implementation of phase I randomized GLASEadjuvanted CH505TF gp120 HIV vaccine trial in newbornsen
dc.journal.volume135en
dc.publisherAMER SOC CLINICAL INVESTIGATION INCen
dc.titleSafety and Implementation of phase I randomized GLASEadjuvanted CH505TF gp120 HIV vaccine trial in newbornsen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.65 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client